Evidence map›Paper›PMID 29731986›Full record

ArticleOncotarget2018

Using weighted regression model for estimating cohort effect in age-period contingency table data.

I-Shiang Tzeng, Chau Yee Ng, Jau-Yuan Chen, Li-Shya Chen, Chin-Chieh Wu

Abstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

I-Shiang TzengDepartment of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
Chau Yee NgDepartment of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taipei, Taiwan.
Jau-Yuan ChenDepartment of Family Medicine, Chang-Gung Memorial Hospital, Linkou Branch, Taoyuan City, Taiwan.
Li-Shya ChenDepartment of Statistics, National Chengchi University, Taipei, Taiwan.
Chin-Chieh WuDepartment of Emergency Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, the multiphase method was proposed to estimate cohort effects after removing the effects of age and period in age-period contingency table data. Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and is strongly associated with cirrhosis, due to both alcohol and viral etiologies. In epidemiology, age-period-cohort (APC) model can be used to describe (or predict) the secular trend in HCC mortality.

resultsThe confidence interval (CI) of the weighted estimates was found to be relatively narrow (compared to unweighted estimates). Moreover, for males, the mortality trend reverses itself during 2006-2010 was found from an increasing trend into a slightly deceasing trend. For females, the increasing trend reverses (earlier than males) itself during 2001-2005.

conclusionsThe weighted estimation of the regression model is recommended for the multiphase method in estimating the cohort effects in age-period contingency table data. IMPACT: The regression model can be modified through the weighted average estimate of the effects with narrower CI of each cohort.

methodsAfter isolating the residuals during the median polish phase, the final phase is to estimate the magnitude of the cohort effects using the regression model of these residuals on the cohort category with the weight equal to the occupied proportion according to the number of death of HCC in each cohort.

Indexed as

age-period-cohorthepatocellular carcinomamultiphase methodprediction

Identifiers

PMID29731986
PMCPMC5929429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.